appointments

News

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

UK start-up George Medicines has named Mark Mallon as its new chief executive, who will oversee the company as it tries to get its triple therapy for high blood pressure o

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires from...

Another light month in March on the agency and investor side, but there are a few appointments worth noting.

Digital

Changing Faces: Digital and supplier hires from March 2024

We’re back with another hires round-up for digital health companies and pharma suppliers. There was plenty of action across the sector in March.

R&D

Changing Faces: Pharma and biotech hires from March 2024

Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.

News

Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Just four months after ending an 18-year stint as chief executive of BioMarin, Jean-Jacques Bienaimé, has been named chairman of Owkin, a specialist in applying artificial

News

Sebastian Guth is promoted to chief operating officer, while Christine Roth will head new global commmercialisation unit

Guth named COO as Bayer revamps top pharma team

Bayer chief executive Bill Anderson has followed through on a pledge to streamline the group’s management, starting at the very top with a big reduction in the pharma unit

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

Changing Faces: Agency, consultancy, and investor hires from...

Changing Faces: Digital and supplier hires from March 2024

Changing Faces: Pharma and biotech hires from March 2024

Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Guth named COO as Bayer revamps top pharma team

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

appointments

Editor's Picks